SCHEMBL7313252

SCHEMBL7313252

O=C(O)CC(Cc1ccccc1)S(=O)(=O)c1cc(-c2ccccc2)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 2/20 0.40
CPB1 P15086 1/20 0.40
CPA3 P15088 1/20 0.40
CPB2 Q96IY4 1/20 0.40
MMP2 P08253 7/20 0.39
MMP9 P14780 6/20 0.39
ADAMTS4 O75173 1/20 0.39
MMP3 P08254 2/20 0.38
MMP1 P03956 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MMP12 P39900 3/20 0.37
MMP13 P45452 2/20 0.37
MMP8 P22894 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MMEL1 Q495T6 1/20 0.36
MMP14 P50281 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306329 0.88 MMP1 (0.53) MMP2MMP9MMP3MMP1PDE4A
SCHEMBL7308114 0.81 MMP2 (0.44) MMP2MMP9ADAMTS4MMP3MMP1
SCHEMBL11828010 0.72 MMP2 (0.50) CPA1CPB1CPA3CPB2MMP2
SCHEMBL11827616 0.71 MMP2 (0.49) CPA1CPB1CPA3CPB2MMP2
SCHEMBL11837183 0.71 MMP2 (0.49) MMP2MMP9ADAMTS4MMP12MMP13
SCHEMBL7302926 0.70 CPA1 (0.44) CPA1CPB1CPA3CPB2MMP2
SCHEMBL27477106 0.70 PPARG (0.52) CPA1CPB1CPA3CPB2MMP2
SCHEMBL27611646 0.70 CPA1 (0.58) CPA1CPB1CPA3CPB2MIF
SCHEMBL7313243 0.69 MMP2 (0.51) CPA1CPB1CPA3CPB2MMP2
SCHEMBL27477107 0.69 PTPRC (0.39) CPA1CPB1CPA3CPB2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed